FTCM
WGS icon

First Trust Capital Management’s GeneDx Holdings WGS Stock Holding History

First Trust Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,718
Closed -$626K – 218
2020
Q4 		$626K Buy
+1,718
New +$599K 0.18% 98

Other funds holding WGS

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Weiss Multi-Strategy Advisers
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Sachem Head Capital Management
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Third Point
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
Jefferies Group
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

First Trust Capital Management's WGS Position: Q1 2021 in Review

First Trust Capital Management sold out of GeneDx Holdings (WGS) in Q1 2021, closing a stake of 1,718 shares — an estimated $626K sold.

First Trust Capital Management first reported a position in WGS in Q4 2020 and held it in 1 quarter. The position peaked at $626K in Q4 2020. 67 funds tracked by Wall St. Rank hold WGS as of Q1 2021.

  • First Trust Capital Management reported no remaining GeneDx Holdings position as of Q1 2021 after selling out during the quarter.
  • First Trust Capital Management sold 1,718 GeneDx Holdings shares in Q1 2021, an estimated $626K.
  • First Trust Capital Management first reported a position in GeneDx Holdings in Q4 2020 and held it in 1 quarter.
  • First Trust Capital Management's GeneDx Holdings position peaked at $626K in Q4 2020.
  • 67 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2021.

Based on First Trust Capital Management's 13F filing for Q1 2021, filed 17 May 2021.